Respiratory Distress Syndrome Market - Global Outlook and Forecast 2022-2028

January 2022 | 65 pages | ID: R321CC9A0501EN
Market Monitor Global

Abstracts

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

This report contains market size and forecasts of Respiratory Distress Syndrome in Global, including the following market information:

Global Respiratory Distress Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Respiratory Distress Syndrome market was valued at 388.6 million in 2021 and is projected to reach US$ 556.5 million by 2028, at a CAGR of 5.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Poractant Alfa Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Respiratory Distress Syndrome include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals and Noargen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Respiratory Distress Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Respiratory Distress Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Respiratory Distress Syndrome Market Segment Percentages, by Type, 2021 (%)

• Poractant Alfa
• Beractant
• Calfactant
• Others

Global Respiratory Distress Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Respiratory Distress Syndrome Market Segment Percentages, by Application, 2021 (%)

• Very Preterm Infants
• Moderate to Late Preterm Infants
• Others

Global Respiratory Distress Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Respiratory Distress Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Respiratory Distress Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Respiratory Distress Syndrome revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Chiesi Farmaceutici
• CR-Double Crane
• ONY Biotech
• AbbVie
• Yuhan Corporation
• JW Pharmaceuticals
• Noargen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Respiratory Distress Syndrome Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Respiratory Distress Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RESPIRATORY DISTRESS SYNDROME OVERALL MARKET SIZE

2.1 Global Respiratory Distress Syndrome Market Size: 2021 VS 2028
2.2 Global Respiratory Distress Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Respiratory Distress Syndrome Players in Global Market
3.2 Top Global Respiratory Distress Syndrome Companies Ranked by Revenue
3.3 Global Respiratory Distress Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Distress Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Respiratory Distress Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Distress Syndrome Players in Global Market
  3.6.1 List of Global Tier 1 Respiratory Distress Syndrome Companies
  3.6.2 List of Global Tier 2 and Tier 3 Respiratory Distress Syndrome Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Respiratory Distress Syndrome Market Size Markets, 2021 & 2028
  4.1.2 Poractant Alfa
  4.1.3 Beractant
  4.1.4 Calfactant
  4.1.5 Others
4.2 By Type - Global Respiratory Distress Syndrome Revenue & Forecasts
  4.2.1 By Type - Global Respiratory Distress Syndrome Revenue, 2017-2022
  4.2.2 By Type - Global Respiratory Distress Syndrome Revenue, 2023-2028
  4.2.3 By Type - Global Respiratory Distress Syndrome Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Respiratory Distress Syndrome Market Size, 2021 & 2028
  5.1.2 Very Preterm Infants
  5.1.3 Moderate to Late Preterm Infants
  5.1.4 Others
5.2 By Application - Global Respiratory Distress Syndrome Revenue & Forecasts
  5.2.1 By Application - Global Respiratory Distress Syndrome Revenue, 2017-2022
  5.2.2 By Application - Global Respiratory Distress Syndrome Revenue, 2023-2028
  5.2.3 By Application - Global Respiratory Distress Syndrome Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Respiratory Distress Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Respiratory Distress Syndrome Revenue & Forecasts
  6.2.1 By Region - Global Respiratory Distress Syndrome Revenue, 2017-2022
  6.2.2 By Region - Global Respiratory Distress Syndrome Revenue, 2023-2028
  6.2.3 By Region - Global Respiratory Distress Syndrome Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Respiratory Distress Syndrome Revenue, 2017-2028
  6.3.2 US Respiratory Distress Syndrome Market Size, 2017-2028
  6.3.3 Canada Respiratory Distress Syndrome Market Size, 2017-2028
  6.3.4 Mexico Respiratory Distress Syndrome Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Respiratory Distress Syndrome Revenue, 2017-2028
  6.4.2 Germany Respiratory Distress Syndrome Market Size, 2017-2028
  6.4.3 France Respiratory Distress Syndrome Market Size, 2017-2028
  6.4.4 U.K. Respiratory Distress Syndrome Market Size, 2017-2028
  6.4.5 Italy Respiratory Distress Syndrome Market Size, 2017-2028
  6.4.6 Russia Respiratory Distress Syndrome Market Size, 2017-2028
  6.4.7 Nordic Countries Respiratory Distress Syndrome Market Size, 2017-2028
  6.4.8 Benelux Respiratory Distress Syndrome Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Respiratory Distress Syndrome Revenue, 2017-2028
  6.5.2 China Respiratory Distress Syndrome Market Size, 2017-2028
  6.5.3 Japan Respiratory Distress Syndrome Market Size, 2017-2028
  6.5.4 South Korea Respiratory Distress Syndrome Market Size, 2017-2028
  6.5.5 Southeast Asia Respiratory Distress Syndrome Market Size, 2017-2028
  6.5.6 India Respiratory Distress Syndrome Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Respiratory Distress Syndrome Revenue, 2017-2028
  6.6.2 Brazil Respiratory Distress Syndrome Market Size, 2017-2028
  6.6.3 Argentina Respiratory Distress Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Respiratory Distress Syndrome Revenue, 2017-2028
  6.7.2 Turkey Respiratory Distress Syndrome Market Size, 2017-2028
  6.7.3 Israel Respiratory Distress Syndrome Market Size, 2017-2028
  6.7.4 Saudi Arabia Respiratory Distress Syndrome Market Size, 2017-2028
  6.7.5 UAE Respiratory Distress Syndrome Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Chiesi Farmaceutici
  7.1.1 Chiesi Farmaceutici Corporate Summary
  7.1.2 Chiesi Farmaceutici Business Overview
  7.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Major Product Offerings
  7.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue in Global Market (2017-2022)
  7.1.5 Chiesi Farmaceutici Key News
7.2 CR-Double Crane
  7.2.1 CR-Double Crane Corporate Summary
  7.2.2 CR-Double Crane Business Overview
  7.2.3 CR-Double Crane Respiratory Distress Syndrome Major Product Offerings
  7.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue in Global Market (2017-2022)
  7.2.5 CR-Double Crane Key News
7.3 ONY Biotech
  7.3.1 ONY Biotech Corporate Summary
  7.3.2 ONY Biotech Business Overview
  7.3.3 ONY Biotech Respiratory Distress Syndrome Major Product Offerings
  7.3.4 ONY Biotech Respiratory Distress Syndrome Revenue in Global Market (2017-2022)
  7.3.5 ONY Biotech Key News
7.4 AbbVie
  7.4.1 AbbVie Corporate Summary
  7.4.2 AbbVie Business Overview
  7.4.3 AbbVie Respiratory Distress Syndrome Major Product Offerings
  7.4.4 AbbVie Respiratory Distress Syndrome Revenue in Global Market (2017-2022)
  7.4.5 AbbVie Key News
7.5 Yuhan Corporation
  7.5.1 Yuhan Corporation Corporate Summary
  7.5.2 Yuhan Corporation Business Overview
  7.5.3 Yuhan Corporation Respiratory Distress Syndrome Major Product Offerings
  7.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue in Global Market (2017-2022)
  7.5.5 Yuhan Corporation Key News
7.6 JW Pharmaceuticals
  7.6.1 JW Pharmaceuticals Corporate Summary
  7.6.2 JW Pharmaceuticals Business Overview
  7.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Major Product Offerings
  7.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue in Global Market (2017-2022)
  7.6.5 JW Pharmaceuticals Key News
7.7 Noargen
  7.7.1 Noargen Corporate Summary
  7.7.2 Noargen Business Overview
  7.7.3 Noargen Respiratory Distress Syndrome Major Product Offerings
  7.7.4 Noargen Respiratory Distress Syndrome Revenue in Global Market (2017-2022)
  7.7.5 Noargen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Respiratory Distress Syndrome Market Opportunities & Trends in Global Market
Table 2. Respiratory Distress Syndrome Market Drivers in Global Market
Table 3. Respiratory Distress Syndrome Market Restraints in Global Market
Table 4. Key Players of Respiratory Distress Syndrome in Global Market
Table 5. Top Respiratory Distress Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Respiratory Distress Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Respiratory Distress Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Respiratory Distress Syndrome Product Type
Table 9. List of Global Tier 1 Respiratory Distress Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Distress Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Respiratory Distress Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Respiratory Distress Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Respiratory Distress Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Respiratory Distress Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Respiratory Distress Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Respiratory Distress Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Respiratory Distress Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Respiratory Distress Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Chiesi Farmaceutici Corporate Summary
Table 31. Chiesi Farmaceutici Respiratory Distress Syndrome Product Offerings
Table 32. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. CR-Double Crane Corporate Summary
Table 34. CR-Double Crane Respiratory Distress Syndrome Product Offerings
Table 35. CR-Double Crane Respiratory Distress Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. ONY Biotech Corporate Summary
Table 37. ONY Biotech Respiratory Distress Syndrome Product Offerings
Table 38. ONY Biotech Respiratory Distress Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Respiratory Distress Syndrome Product Offerings
Table 41. AbbVie Respiratory Distress Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. Yuhan Corporation Corporate Summary
Table 43. Yuhan Corporation Respiratory Distress Syndrome Product Offerings
Table 44. Yuhan Corporation Respiratory Distress Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. JW Pharmaceuticals Corporate Summary
Table 46. JW Pharmaceuticals Respiratory Distress Syndrome Product Offerings
Table 47. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. Noargen Corporate Summary
Table 49. Noargen Respiratory Distress Syndrome Product Offerings
Table 50. Noargen Respiratory Distress Syndrome Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Respiratory Distress Syndrome Segment by Type in 2021
Figure 2. Respiratory Distress Syndrome Segment by Application in 2021
Figure 3. Global Respiratory Distress Syndrome Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Respiratory Distress Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Respiratory Distress Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Distress Syndrome Revenue in 2021
Figure 8. By Type - Global Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 12. US Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 24. China Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Respiratory Distress Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Respiratory Distress Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CR-Double Crane Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ONY Biotech Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AbbVie Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Yuhan Corporation Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. JW Pharmaceuticals Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Noargen Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)